Invivyd, Inc.

IVVD Nasdaq CIK: 0001832038

Company Information

Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation DE
Business Address 209 CHURCH STREET, NEW HAVEN, CT, 06510
Mailing Address 209 CHURCH STREET, NEW HAVEN, CT, 06510
Phone (781) 819-0080
Fiscal Year End 1231
EIN 851403134

Financial Overview

FY2025

-$52.49M
Net Income
$-0.30
EPS

Recent SEC Filings

Form Type Date Filed Document
8-K Current report of material events March 5, 2026 View on SEC
10-K Annual financial report March 5, 2026 View on SEC
4 Insider stock transaction report February 18, 2026 View on SEC
4 Insider stock transaction report February 18, 2026 View on SEC
4 Insider stock transaction report February 18, 2026 View on SEC
4 Insider stock transaction report February 18, 2026 View on SEC
4 Insider stock transaction report February 18, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 17, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 17, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 17, 2026 View on SEC

Annual Reports

10-K March 5, 2026
  • Lead candidate INV-123 advanced to pivotal Phase 3 clinical trials in Q4 2025 after positive Phase 2 results.
  • Secured a key strategic collaboration agreement in Q3 2025, providing non-dilutive funding and expertise.
View Analysis

Insider Trading

SELL 5 insiders 10 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2836)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.